Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Am J Kidney Dis. 2017 Dec 6;71(5):657–665. doi: 10.1053/j.ajkd.2017.09.015

Figure 2.

Figure 2

Figure 2

Repeated measures of weight and body mass index with advancing CKD.

A. Longitudinal repeated measures of weight with repeated measures of eGFR by cystatin C in CRIC.

B. Longitudinal repeated measures of BMI with repeated measures of eGFR by cystatin C in CRIC.

C. Longitudinal repeated measures of weight with repeated measures of eGFR by creatinine in CRIC.

D. Longitudinal repeated measures of BMI with repeated measures of eGFR by creatinine in CRIC.

E. Longitudinal repeated measures of weight with repeated measures of eGFR by creatinine in AASK.

F. Longitudinal repeated measures of BMI with repeated measures of eGFR by creatinine in AASK.

---- 95% CI

**The figure shows repeated measurements of weight (or BMI) with repeated measures of eGFR among the same participants over time. In general, weight (or BMI) is noted to be stable until around eGFR of 35 mL/min/1.73 m2, when steeper declines in weight (or BMI) are noted to occur.